Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

NEO Stock Forecast, Price Targets, Chart, Dividends & Analysis

NeoGenomics Inc. logo

NeoGenomics Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

14.12
 
USD
  
-0.22
  
(-1.53%)
Previous close: 14.34  Open: 14.14  Bid: 14.0  Ask: 14.4
52 week range    
11.65   
   21.22
Mkt Cap: 1,770 M  Avg Vol (90 Days): 739,247
Peers   
BRLI / 
RDNT / 
DGX / 
LH / 
PMD / 
ENZ / 
Last updated: Friday 4th October 2024

Stock Rankings

40
MarketXLS Rank
60
Value
15
Technical
47
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BRLI

DGX

0.019317 B20.67152.13

ENZ

0 B11.13

GNLKQ

LH

0.012918 B41.74215.07

PMD

0 B-32.305

RDNT

5 B386.8967.67
Financials

NEO Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends122000.025 M11 M-3 M
Amortization of intangibles-295000.0-412000.0-7 M-7 M-6 M199 M211 M527 M523 M523 M
Basic EPS from continuing operations0.02-0.04-0.39-0.140.070.080.04-0.07-1.16-0.7
Basic EPS total0.02-0.040.080.04-0.07-1.16-0.7
Basic weighted shares outstanding53 M61 M78 M79 M86 M100 M109 M120 M124 M126 M
Cost of sales-46 M-56 M-134 M-138 M-149 M212 M259 M297 M322 M347 M
Depreciation20 M26 M30 M35 M37 M
Depreciation unreconciled-5 M-7 M-16 M-16 M-16 M
DepreciationAndAmortization-5 M-7 M-16 M-16 M-16 M20 M26 M30 M35 M37 M
Diluted EPS total0.02-0.040.080.04-0.07-1.16-0.7
Diluted normalized net income/share0.02-0.04-0.39-0.140.070.080.04-0.07-1.16-0.7
Diluted weighted shares outstanding56 M61 M78 M79 M92 M104 M112 M120 M124 M126 M
GainOnSaleOfBusiness-1 M
GeneralAndAdministrativeExpense24 M34 M76 M70 M85 M128 M144 M221 M243 M243 M
Gross operating profit41 M44 M110 M102 M127 M197 M186 M187 M188 M245 M
ImpairmentOfCapitalAssets3 M253000.0718000.0
Income before tax1 M-4 M-7 M-3 M4 M4 M-14 M-15 M-159 M-97 M
Income restructuring and M&A5 M11 M
Income taxes157000.0-2 M-2 M-2 M1 M-4 M-18 M-7 M-15 M-9 M
Interest income-929000.0
InterestExpenseNonOperating985000.0854000.0-738000.0-695000.06 M4 M7 M8 M8 M7 M
InterestIncomeOperating6 M17 M
MiscOtherSpecialCharges56000.02 M240 M277 M-6 M7 M-499000.0-213000.0644000.0
Net income from total operations1 M-3 M-6 M-396000.03 M8 M4 M-8 M-144 M-88 M
NetIncomeCommonStockholders1 M-3 M-30 M-11 M6 M8 M4 M-8 M-144 M-88 M
NetIncomeContinuousOperations1 M-3 M-6 M-396000.03 M8 M4 M-8 M-144 M-88 M
NetNonOperatingInterestIncomeExpense-985000.0-854000.0-10 M-6 M-6 M-4 M-7 M-5 M-8 M-7 M
NetOperatingInterestIncomeExpense6 M
Normalized income-95 M
Operating income2 M-6 M6 M-236 M-267 M13 M-14 M-119 M-158 M-108 M
Operating income before depreciation (EBITDA)8 M4 M19 M19 M32 M38 M29 M46 M-82 M-18 M
OperatingExpense-38 M-49 M-108 M-99 M-117 M184 M200 M306 M346 M352 M
Other income net-56000.0-2 M-6 M-239 M-277 M6 M-7 M499000.0213000.0-644000.0
OtherGandA24 M34 M76 M70 M85 M128 M144 M221 M243 M243 M
OtherImpairmentOfCapitalAssets-3 M
OtherOperatingExpenses-2 M-2 M-12 M-99 M-117 M-378000.0-632000.0-726000.0-5 M
OtherWriteOff-3 M-2 M-3 M-19 M
OtherunderPreferredStockDividend122000.025 M11 M-3 M
PreferredStockDividends122000.025 M11 M-3 M
RentAndLandingFees24 M34 M76 M70 M85 M
Research & development expense3 M4 M5 M4 M3 M8 M8 M22 M30 M27 M
ResearchExpense3 M4 M5 M4 M3 M8 M8 M22 M30 M27 M
RestructringAndMnAIncome5 M11 M
Revenue per share-295000.0-412000.0-7 M-7 M-7 M200 M212 M528 M524 M524 M
SalariesAndWages-641000.0-2 M-2 M
Selling Gen & administrative expense36 M45 M100 M94 M114 M175 M192 M284 M311 M314 M
SellingAndMarketingExpense12 M12 M24 M24 M29 M47 M48 M63 M67 M71 M
SellingExpense12 M12 M24 M24 M29 M
Special income/charges-3 M-253000.0-5 M-11 M
Total Income available for interest expense (EBIT)2 M-4 M-8 M-4 M10 M7 M-7 M-7 M-152 M-90 M
Total common shares outstanding121 M152 M158 M161 M189 M210 M117 M124 M127 M128 M
Total net income1 M-3 M-6 M-396000.03 M8 M4 M-8 M-144 M-88 M
Total ordinary shares128 M128 M128 M128 M128 M128 M128 M128 M128 M128 M
Total revenues87 M100 M244 M259 M277 M409 M444 M484 M510 M592 M
TotalExpenses-85 M-105 M-242 M-237 M-267 M396 M458 M603 M667 M699 M
TotalRevenue87 M100 M232 M240 M277 M409 M444 M484 M510 M592 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University